Graft function and outcome of older (≥60 years) donor livers

Transplantation

Volumn 61, Issue 7, 1996, Pages 1062-1066

  Washburn, W Kenneth ^a   Johnson, Lynt B ^a   Lewis, W David ^a   Jenkins, Roger L ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; AGE; AGED; ARTICLE; CHOLESTASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROTHROMBIN TIME; REOPERATION; STEATOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0030005910     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604150-00013     Document Type: Article

References (15)

1. Mor E, Klintmalm GBG, Gonwa TA, et al. The use of marginal donors for liver transplantation. Transplantation 1992; 53: 383.
2. Wall WJ, Mimeault R, Grant DR, Block M. The use of older donor livers for hepatic transplantation. Transplantation 1990; 49: 377.
3. Broelsch CE, Emond JC, Whittington PF, et al. Application of reduced-sized liver transplants as grafts, auxiliary orthotopic grafts, and living-related segmental transplants. Ann Surg 1990; 212: 368.
4. Starzl TE, Fung JJ, Tzakis AG, et al. Baboon-to-human liver transplantation. Lancet 1993; 341: 65.
5. Casavilla A, Ramirez C, Shapiro R, et al. Experience with liver and kidney allografts from non-heart beating donors. Transplantation 1995; 69: 197.
6. Alexander JW, Vaughn WK. The use of "marginal" donors for organ transplantation. Transplantation 1991; 51: 135.
7. Adam R, Astarcioglu F, Azoulay D, et al. Age greater than 50 years is not a contraindication for liver donation. Transplant Proc 1991; 23: 2602.
8. Marino IR, Doyle HR, Aldrighetti DL, et al. Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc 1995; 27: 1184.
9. Pruim J, van Woerden WF, Knolf E, et al. Donor data in liver grafts with primary non-function: a preliminary analysis by the European liver registry. Transplant Proc 1989; 21: 2383.
10. Shaw BW, Wood RP, Stratta RJ, Pillen TJ, Langnas AN. Stratifying the cause of death in liver transplant recipients. Arch Surg 1989; 124: 895.
11. Adam R, Sanchez C, Astarcioglu E, Bismuth H. Deleterious effect of extended cold ischemia time on the posttransplant outcome of aged livers. Transplant Proc 1995; 27: 1181.
12. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation: a multivariate analysis. Transplantation 1993; 55: 807.
13. Haller GW, Langrehe JM, Blumhardt G, et al. Factors relevant to the development of primary dysfunction in liver allografts. Transplant Proc 1995; 27: 1192.
14. D'Alessandro AM, Kalayoglu M, Sollinger HW, et al. The predictive value of donor liver biopsies for the development of non-function after orthotopic liver transplantation. Transplantation 1991; 51: 157.
15. Buckel I, Sanchez-Urdazpal L, Steers J, Sterioft S, Weisner B, Krom RAF. Impaired initial function in liver grafts from donors >50 years of age. Transplant Proc 1993; 25: 1558.